Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$968K Buy
8,386
+1,480
+21% +$168K 0.11% 130
2023
Q1
$735K Buy
+6,906
New +$746K 0.11% 141
2022
Q2
$891K Sell
9,772
-6,299
-39% -$558K 0.24% 64
2022
Q1
$1.32M Buy
+16,071
New +$1.27M 0.21% 77
2021
Q3
$391K Sell
5,212
-285
-5% -$21.7K 0.07% 122
2021
Q2
$427K Sell
5,497
-131
-2% -$9.74K 0.09% 122
2021
Q1
$414K Sell
5,628
-541
-9% -$39.9K 0.12% 116
2020
Q4
$481K Sell
6,169
-1,651
-21% -$126K 0.16% 89
2020
Q3
$577K Buy
+7,820
New +$613K 0.24% 62

Other funds holding MRK

Leo Brokerage's MRK Position: Q2 2023 in Review

Leo Brokerage increased its Merck (MRK) stake by 21% in Q2 2023, buying an estimated $168K and bringing the position to 8,386 shares worth $968K. The position accounts for 0.11% of the portfolio, ranked #130.

Leo Brokerage first reported a position in MRK in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.32M in Q1 2022. 3,257 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Leo Brokerage held 8,386 shares of Merck worth $968K as of Q2 2023.
  • Leo Brokerage bought 1,480 Merck shares in Q2 2023, an estimated $168K.
  • Merck made up 0.11% of Leo Brokerage's portfolio in Q2 2023, its #130 holding.
  • Leo Brokerage first reported a position in Merck in Q3 2020 and has held it in 9 quarters since.
  • Leo Brokerage's Merck position peaked at $1.32M in Q1 2022.
  • 3,257 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.